Skip to content
Search

Latest Stories

Invatech Health completes £2.2 million funding for pharmacy software Titan

Invatech Health has secured an award of £900,000 from Innovate UK for its cutting-edge pharmacy software Titan.

The latest round of funding takes the total amount the Bristol-based firm received under a competitive programme to support SME innovations to £2.2 million.


“Innovate UK is pleased to support Invatech Health in its important and highly innovative development of Titan PMR for the pharmacy sector,” commented Nigel Walker, deputy director at Innovate UK, which is part of the national funding agency UK Research and Innovation.

“The business has met all the objectives established during the first phase of the loan arrangement and we are delighted to provide further funding to support the company’s ongoing innovations.”

Invatech received an initial loan in February 2018 for the development of Titan, which is complemented by further grant funding during the Covid-19 pandemic to support remote working for independent pharmacists.

Tariq Muhammad, chief executive of Invatech Health, said the latest funding will support the development of new features for the company’s leading platform.

“With this additional support from Innovate UK we plan to develop a wide range of new game-changing apps, delivered as extensions on the Titan platform,” he said. “These will help address the new and immediate challenges that pharmacies are facing as a result of Covid-19 and provide innovative solutions to support their businesses and their patients in the long term.”

Muhammad added that the pandemic has shone light on the shortcomings of old technology across the sector, among large online businesses and small independents alike.

“This crisis has highlighted the incapacity of legacy systems to scale up and adapt to dynamic situations, in many business sectors,” he commented.

“The pandemic has put pharmacies are under significant pressure and there is a need for technology that can help them cope with greater volume of work, as well as releasing pharmacists time to spend on frontline healthcare.”

A cloud-based solution, Titan digitises the end-to-end workflow within pharmacies, makes medicine dispensing safer using barcode technology, helps control business activities and improves the experience for patients and practice owners alike, freeing up pharmacists’ time in the process to help them focus on newly-commissioned patient services designed to relieve the burden from under-pressure GPs and the wider NHS.

The solution became the first pharmacy Patient Medication Record (PMR) to get accredited by NHS in one and a half decade, and since the feat in late 2019, it has cornered two per cent market share, processing over 1.5 million prescriptions per month.

The technology has also become the platform of choice for some of the largest UK online pharmacies which have leveraged its highly scalable cloud infrastructure to process mass volumes and, in some cases, over 60,000 prescriptions per day.

“We’re delighted with the progress that Titan has made, commercially and operationally, over the past two years. We have taken an idea and built something which is helping independent pharmacy businesses and large scale operators alike,” Muhammad said.

“With 5,000 independent and small group pharmacists in England and Wales, alongside the larger corporates, the commercial potential for Titan is massive. We’re fundamentally different to all other PMRs and are offering a new way of life for pharmacists and a new way of doing things.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less